Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Antiperspirant for Capecitabine-Induced Hand-Foot Syndrome
NCT00213993Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aluminum chlorohydrate in palmar-plantar erythrodysesthesia (PPE), sponsored by University of Wisconsin–Madison. Started May 2005; status: completed.
02
Drugs
aluminum chlorohydrate
03
Conditions
palmar-plantar erythrodysesthesia (PPE)
Beyond the preview
Go deeper on NCT00213993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213993.